HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shunichi Yamashita Selected Research

protease S

2/2021Cellular Mechanism Underlying Highly-Active or Antiretroviral Therapy-Induced Lipodystrophy: Atazanavir, a Protease Inhibitor, Compromises Adipogenic Conversion of Adipose-Derived Stem/Progenitor Cells through Accelerating ER Stress-Mediated Cell Death in Differentiating Adipocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shunichi Yamashita Research Topics

Disease

51Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 07/2002
50Neoplasms (Cancer)
01/2022 - 01/2002
21Papillary Thyroid Cancer
01/2022 - 07/2002
9Carcinogenesis
01/2016 - 01/2002
6Anaplastic Thyroid Carcinoma
01/2019 - 04/2003
6Adenoma (Adenomas)
03/2015 - 07/2002
6Carcinoma (Carcinomatosis)
06/2012 - 10/2002
4Obesity
11/2019 - 01/2014
4Fibrosis (Cirrhosis)
06/2012 - 08/2002
3Thyroid Nodule (Nodule, Thyroid)
11/2020 - 02/2011
3Liver Diseases (Liver Disease)
04/2017 - 01/2014
3Hypertension (High Blood Pressure)
01/2015 - 01/2007
3Keloid
06/2012 - 06/2003
3Papillary Carcinoma
06/2004 - 07/2002
2Lipodystrophy
02/2021 - 11/2019
2Hypothyroidism
11/2020 - 01/2016
2Wounds and Injuries (Trauma)
11/2019 - 06/2010
2Thyroid Diseases (Thyroid Disease)
10/2019 - 06/2004
2Chromosome Aberrations (Chromosome Abnormalities)
01/2017 - 07/2012
2Hyperuricemia
01/2015 - 01/2014
2Hyperlipidemias (Hyperlipidemia)
01/2015 - 01/2014
2Genomic Instability
03/2014 - 03/2008
2Ataxia Telangiectasia (Louis Bar Syndrome)
12/2011 - 07/2010
2Esophageal Squamous Cell Carcinoma
03/2011 - 05/2010
2Radiation Injuries (Radiation Sickness)
12/2010 - 06/2010
2Inflammation (Inflammations)
09/2008 - 08/2005
2Pituitary Neoplasms (Pituitary Adenoma)
08/2007 - 11/2005
2Gastroesophageal Reflux (GERD)
04/2004 - 12/2003
1Squamous Cell Carcinoma of Head and Neck
01/2021
1Retinoblastoma (Glioblastoma, Retinal)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2019
1Lymphedema (Milroy Disease)
01/2019
1Radiation-Induced Neoplasms (Neoplasms, Radiation Induced)
01/2018

Drug/Important Bio-Agent (IBA)

13IodineIBA
10/2019 - 06/2004
8Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2002
8Messenger RNA (mRNA)IBA
01/2019 - 05/2002
7NF-kappa B (NF-kB)IBA
11/2008 - 01/2004
6DNA (Deoxyribonucleic Acid)IBA
12/2020 - 12/2002
6Cyclin D1IBA
11/2007 - 01/2002
5Biological ProductsIBA
11/2019 - 11/2005
4ThyroglobulinFDA Link
01/2018 - 01/2004
4MicroRNAs (MicroRNA)IBA
06/2012 - 06/2008
4Phosphotransferases (Kinase)IBA
11/2007 - 03/2006
4Transforming Growth Factor beta (TGF-beta)IBA
01/2007 - 08/2002
4beta CateninIBA
04/2004 - 01/2002
3Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2018 - 03/2014
3dehydroxymethylepoxyquinomicinIBA
11/2008 - 10/2004
3Folic Acid (Vitamin M)FDA LinkGeneric
09/2008 - 10/2004
3GhrelinIBA
08/2005 - 09/2004
3ParaffinIBA
09/2003 - 06/2002
2Indicators and Reagents (Reagents)IBA
01/2021 - 01/2007
2NitratesIBA
01/2021 - 01/2015
2ErbB Receptors (EGF Receptor)IBA
01/2021 - 05/2012
2Glucose (Dextrose)FDA LinkGeneric
01/2015 - 01/2014
2Capsules (Microcapsules)IBA
01/2014 - 02/2011
2Transcription Factors (Transcription Factor)IBA
07/2013 - 02/2002
2Imatinib Mesylate (Gleevec)FDA Link
07/2012 - 04/2003
2Tyrosine Kinase InhibitorsIBA
07/2012 - 04/2003
2Annexin A5IBA
11/2008 - 10/2004
2Collagen Type I (Type I Collagen)IBA
09/2008 - 06/2003
2Liposomes (Liposome)IBA
08/2007 - 03/2006
2LuciferasesIBA
08/2007 - 03/2006
2Growth Hormone (Somatotropin)IBA
08/2007 - 01/2007
2Thymidine KinaseIBA
08/2007 - 03/2006
2Lansoprazole (Prevacid)FDA LinkGeneric
08/2005 - 04/2004
2A-factor (Streptomyces)IBA
05/2005 - 04/2004
2Mitochondrial DNA (mtDNA)IBA
06/2004 - 12/2002
2AntigensIBA
04/2004 - 01/2004
2Interleukin-8 (Interleukin 8)IBA
04/2004 - 12/2003
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2003 - 11/2002
2p38 Mitogen-Activated Protein KinasesIBA
06/2003 - 08/2002
2LigandsIBA
11/2002 - 05/2002
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1Atazanavir Sulfate (Reyataz)FDA Link
02/2021
1protease SIBA
02/2021
1Protease Inhibitors (Protease Inhibitor)IBA
02/2021
1Protein SIBA
02/2021
1Cetuximab (Erbitux)FDA Link
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Iodine-131IBA
11/2020
1AgarIBA
01/2019
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2019
1APTIBA
10/2018
1Cadherins (E-Cadherin)IBA
10/2018
1VimentinIBA
10/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1polyalanineIBA
01/2017
1ORALIT (ORS)IBA
08/2016
1Colloids (Colloid)IBA
01/2016
1Thyroid HormonesIBA
01/2016

Therapy/Procedure

22Nuclear Power Plants
07/2020 - 05/2005
19Therapeutics
01/2022 - 10/2002
6Radiotherapy
11/2020 - 01/2002
2Highly Active Antiretroviral Therapy (HAART)
02/2021 - 11/2019
2Lymph Node Excision (Lymph Node Dissection)
01/2019 - 04/2006
2Thyroidectomy
01/2012 - 04/2006
2Molecular Targeted Therapy
08/2009 - 01/2009
2Drug Therapy (Chemotherapy)
11/2008 - 01/2007
2Immunotherapy
01/2007 - 01/2004
1Art Therapy
02/2021